Barclays PLC (BCS) Stock Price Today
Hydrogen and fuel cell stocks drop as rising Treasury yields pressure valuations and borrowing costs.
Hydrogen and fuel cell stocks, including Plug Power, Bloom Energy, and FuelCell Energy, fell due to rising 10-year Treasury yields nearing their 52-week high. Higher yields increase discount rates, reducing the present value of these companies' long-...
Visa seeks new stablecoin partner after Mastercard's BVNK acquisition to support multi-region licensing.
Visa is looking for a new stablecoin settlement partner with multi-regional licenses to replace BVNK, recently acquired by Mastercard. This move supports the Open USD stablecoin project led by Stripe, Visa, and Mastercard, aiming to enable interopera...
Santhera nears cash break-even as AGAMREE adoption grows in Europe
Santhera Pharmaceuticals is approaching cash flow break-even in Q3 2026, driven by strong uptake of its drug AGAMREE for Duchenne muscular dystrophy in Europe. AGAMREE, a corticosteroid with fewer side effects, has captured significant market share i...
US pending home sales drop 2.3% in July, signaling housing market struggles amid high mortgage rates.
The US pending home sales index fell 2.3% in July, missing expectations of a slight rise, as high mortgage rates and record home prices continue to deter buyers. Sales declined across all regions month-over-month, with year-over-year drops in most ar...
Shareholders of iTonic Holdings urged to join class action over alleged stock manipulation and misleading statements.
The Gross Law Firm has announced a class action lawsuit for shareholders of iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) who bought shares between September 5, 2024, and July 29, 2025. The lawsuit alleges the company and its affiliates engage...
Shareholders of Replimune Group urged to join class action over alleged misleading FDA data disclosures.
The Gross Law Firm has announced a class action lawsuit for shareholders of Replimune Group, Inc. who bought shares between October 20, 2025, and April 10, 2026. The lawsuit alleges that Replimune made false or misleading statements about its FDA Bio...
Kailera Therapeutics shares dip amid Phase 3 obesity drug trials and strategic partnership updates.
Kailera Therapeutics recently closed at $18.51, down 2.5% for the week and 28.8% since its April IPO. The clinical-stage company, with no product revenue, holds $1.17 billion in cash and has a runway into mid-2028. Its lead drug, ribupatide, is in gl...
Disney's ABC sues FCC over alleged retaliatory license review tied to political bias claims
Disney's ABC has filed a lawsuit against the Federal Communications Commission (FCC), accusing the Trump administration of retaliating against the network for its critical coverage by launching an early review of its broadcast licenses. The suit clai...
Janus Living raises $2.15B to acquire senior housing amid strong demand and minimal new supply.
Janus Living (JAN) raised $2.15 billion through equity issuance to capitalize on the senior housing sector, which is experiencing strong capital inflows but minimal new development. This unique market condition allows JAN to acquire properties at att...
High yields on cyclical stocks like B&G Foods, ZIM, and TXO signal risk as dividends depend on volatile market cycles.
Cyclical stocks such as B&G Foods, ZIM Integrated Shipping Services, and TXO Partners offer high dividend yields that fluctuate with market conditions like shipping rates, food margins, and oil prices. These dividends are risky because they depend on...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.